OQROGet OQRO Pro
Insider trade

Cytosorbents (CTSO)CEO bought ~$23K

Phillip P. Chan, CEO at Cytosorbents, bought ~$23K of Cytosorbents shares.

~$23K
Approx. value · 3,774 sh @ $6.00
101K
Holds after · shares reported
Traded
Sep 15, 2026
Filed
Sep 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  2. Sep 4, 2026InsiderCEO purchased ~$70K of CTSO shares in the open market
  3. Sep 8, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  4. Sep 14, 2026Insider · 1 personInsiders: 2 purchases (~$13K)
  5. Sep 15, 2026 · this disclosureInsider · 3 insiders in a week, 3rd time since 2006CEO purchased ~$23K of CTSO shares in the open market

What came next

  1. Sep 15, 2026Insider · 1 personInsiders: 3 purchases (~$15K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytosorbents

For Cytosorbents, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CTSO page.

Other recent filings by Phillip P. Chan, Chief Executive Officer

The full history of Phillip P. Chan, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Cytosorbents

Everything OQRO holds on this company is on its CTSO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data